We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 975.00 | 974.00 | 978.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.72 | 700.64M |
From Apr 2021 to Apr 2024
TIDMCVSG
RNS Number : 1202X
CVS Group plc
30 April 2021
30 April 2021
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services, confirms that certain employees have exercised options during April under the Company's Save As You Earn (SAYE) 2021 scheme (together, the "SAYE Exercise") totalling 8,080 ordinary shares of 0.2 pence each ("Ordinary Shares").
None of the options exercised were satisfied using the Company's Employee Benefit Trust ("EBT") which continues to hold 710 shares . Admission of the 8,080 new Ordinary Shares has been satisfied via the Company's existing block listing.
Following the issue of these new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, the Company has a total issued share capital of 70,733,708 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 70,733,708.
This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts:
CVS Group Plc Tel: +44 1379 644 288
Michelle Barker, Company Secretary
N+1 Singer (Nominated Adviser & Broker) Tel: +44 20 7496 3000
Aubrey Powell/ Jen Boorer /Rachel Hayes
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEBSGDSXDDDGBC
(END) Dow Jones Newswires
April 30, 2021 07:00 ET (11:00 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
